Newly Identifed Biomarkers for Detecting Circulating Tumor Cells in Lung Adenocarcinoma

Tohoku Journal of Experimental Medicine

Volumn 234, Issue 1, 2014, Pages 29-40

  Man, Yingchun ^a,b   Cao, Jingyan ^a   Jin, Shi ^a   Xu, Gang ^a   Pan, Bo ^a   Shang, Lihua ^a   Che, Dehai ^a   Yu, Qin ^a   Yu, Yan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Hospital   (China)

Author keywords

Ca2+ activated chloride channel 2; Circulating tumor cells; Cytokeratin 7; Hyaluronan mediated motility receptor; Telomerase catalytic subunit

Indexed keywords

CALCIUM ACTIVATED CHLORIDE CHANNEL 2; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CERULOPLASMIN; COLLAGEN TYPE 11 ALPHA 1; CXCL13 CHEMOKINE; CYTOKERATIN 7; DNA TOPOISOMERASE II ALPHA 170KDA; DUAL SPECIFICITY PHOSPHATASE 6; GREMLIN 1; HYALURONAN MEDIATED MOTILITY RECEPTOR; INTERFERON REGULATORY FACTOR 4; INTERSTITIAL COLLAGENASE; LIPOCORTIN 5; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE; MACROPHAGE ELASTASE; MARKER OF PROLIFERATION KI 67; MESSENGER RNA; MONOCYTE TO MACROPHAGE DIFFERENTIATION ASSOCIATED PROTEIN; NEUROFIBROMIN; OSTEOPONTIN; SCATTER FACTOR; SERINE PROTEINASE INHIBITOR KAZAL TYPE 1; STAT1 PROTEIN; STAT2 PROTEIN; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE; THYROID TRANSCRIPTION FACTOR 1; TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TUMOR MARKER; UNCLASSIFIED DRUG; CHLORIDE CHANNEL; CLCA2 PROTEIN, HUMAN; HERMES ANTIGEN; HYALURONAN-MEDIATED MOTILITY RECEPTOR; SCLEROPROTEIN; TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; ANXA5 GENE; ARTICLE; CANCER PROGNOSIS; CEACAM5 GENE; CIRCULATING TUMOR CELL; CK7 GENE; CLCA2 GENE; COL11A1 GENE; CONTROLLED STUDY; CP GENE; CXCL13 GENE; CYTODIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DUSP6 GENE; FEMALE; FOLLOW UP; GENE; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GREM1 GENE; HGF GENE; HMMR GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRF4 GENE; LCK GENE; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MKI67 GENE; MMD GENE; MMP1 GENE; MMP12 GENE; MRNA GENE; NF1 GENE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPINK1 GENE; SPP1 GENE; STAT1 GENE; STAT2 GENE; SURVIVAL TIME; TOP2A GENE; TOX3 GENE; UPREGULATION; VALIDATION PROCESS; VERY ELDERLY; ADENOCARCINOMA; ANALYSIS OF VARIANCE; CHEMISTRY; GENETIC ASSOCIATION; GENETICS; LUNG NEOPLASMS; METABOLISM; NONPARAMETRIC TEST; TUMOR EMBOLISM;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANTIGENS, CD44; CHLORIDE CHANNELS; EXTRACELLULAR MATRIX PROTEINS; GENETIC ASSOCIATION STUDIES; HUMANS; KERATIN-7; LUNG NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84919351566     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.234.29     Document Type: Article

References (38)

1. Allan, A.L. & Keeney, M. (2010) Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J. Oncol., 2010, 426218.
2. Bunn, P.A. Jr. (2012) Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch. Pathol. Lab. Med., 136, 1478-1481.
3. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J. & Wittwer, C.T. (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem., 55, 611-622.
4. Camilo, R., Capelozzi, V.L., Siqueira, S.A. & Del Carlo Bernardi, F. (2006) Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas. Hum. Pathol., 37, 542-546.
5. Cen, P., Ni, X., Yang, J., Graham, D.Y. & Li, M. (2012) Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim. Biophys. Acta, 1826, 350-356.
6. Dukic, N., Babic, B., Eri, Z., Zec, D., Lovrenski, A. & Kolarov, V. (2011) Bronchioloalveolar differentiation in lung adenocarci-nomas. Bosn. J. Basic Med. Sci., 11, 248-252.
7. Ghossein, R.A., Bhattacharya, S. & Rosai, J. (1999) Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin. Cancer Res., 5, 1950-1960.
8. Gruber, A.D., Schreur, K.D., Ji, H.L., Fuller, C.M. & Pauli, B.U. (1999) Molecular cloning and transmembrane structure of hCLCA2 from human lung, trachea, and mammary gland. Am. J. Physiol., 276, C1261-1270.
9. Hayes, D.C., Secrist, H., Bangur, C.S., Wang, T., Zhang, X., Harlan, D., Goodman, G.E., Houghton, R.L., Persing, D.H. & Zehentner, B.K. (2006) Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res., 26, 1567-1575.
10. Helo, P., Cronin, A.M., Danila, D.C., Wenske, S., Gonzalez-Espinoza, R., Anand, A., Koscuiszka, M., Vaananen, R.M., Pettersson, K., Chun, F.K., Steuber, T., Huland, H., Guillonneau, B.D., Eastham, J.A., Scardino, P.T., et al. (2009) Circulating prostate tumor cells detected by reverse transcription-pcr in men with localized or castration-refractory prostate cancer: Concordance with cellsearch assay and association with bone metas-tases and with survival. Clin. Chem., 55, 765-773.
11. Ikeda, S., Fujimori, M., Shibata, S., Okajima, M., Ishizaki, Y., Kurihara, T., Miyata, Y., Iseki, M., Shimizu, Y., Tokumoto, N., Ozaki, S. & Asahara, T. (2006) Combined immunohistochem-istry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer. BMC Cancer, 6, 31.
12. Jacob, K., Sollier, C. & Jabado, N. (2007) Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev. Proteomics, 4, 741-756.
13. Leelawat, K., Narong, S., Udomchaiprasertkul, W., Wannaprasert, J., Treepongkaruna, S.A., Subwongcharoen, S. & Ratanashu-ek, T. (2012) Prognostic relevance of circulating CK19 mRMA in advanced malignant biliary tract diseases. World J. Gastroen-terol., 18, 175-181.
14. Liu, X.F., Bera, T.K., Kahue, C., Escobar, T., Fei, Z., Raciti, G.A. & Pastan, I. (2012) ANKRD26 and its interacting partners trio, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cells. PLoS One, 7, e38130.
15. Maheswaran, S. & Haber, D.A. (2010) Circulating tumor cells: a window into cancer biology and metastasis. Curr. Opin. Genet. Dev., 20, 96-99.
16. Mavroudis, D. (2010) Circulating cancer cells. Ann. Oncol., 21 Suppl 7, 95-100.
17. Maxwell, C.A., McCarthy, J. & Turley, E. (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J. Cell Sci., 121, 925-932.
18. Melin, B.S., Nordfjall, K., Andersson, U. & Roos, G. (2012) hTERT cancer risk genotypes are associated with telomere length. Genet. Epidemiol., 36, 368-372.
19. Miao, X.H., Yao, Y.W., Yuan, D.M., Lv, Y.L., Zhan, P., Lv, T.F., Liu, H.B. & Song, Y. (2012) Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma: a meta-analysis. J. Thorac. Dis., 4, 265-271.
20. Mostert, B., Sleijfer, S., Foekens, J.A. & Gratama, J.W. (2009) Circulating tumor cells (CTCS): detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev., 35, 463-474.
21. Nagrath, S., Sequist, L.V., Maheswaran, S., Bell, D.W., Irimia, D., Ulkus, L., Smith, M.R., Kwak, E.L., Digumarthy, S., Muzikansky, A., Ryan, P., Balis, U.J., Tompkins, R.G., Haber, D.A. & Toner, M. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature, 450, 1235-1239.
22. Okumura, Y., Tanaka, F., Yoneda, K., Hashimoto, M., Takuwa, T., Kondo, N. & Hasegawa, S. (2009) Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann. Thorac. Surg., 87, 1669-1675.
23. Pak, M.G., Shin, D.H., Lee, C.H. & Lee, M.K. (2012) Signifcance of EpCAM and TROP2 expression in non-small cell lung cancer. World J. Surg. Oncol., 10, 53.
24. Paterlini-Brechot, P. & Benali, N.L. (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett., 253, 180-204.
25. Samuel, N. & Hudson, T.J. (2013) Translating genomics to the clinic: implications of cancer heterogeneity. Clin. Chem., 59, 127-137.
26. Sanchez-Palencia, A., Gomez-Morales, M., Gomez-Capilla, J.A., Pedraza, V., Boyero, L., Rosell, R. & Farez-Vidal, M.E. (2011) Gene expression profling reveals novel biomarkers in nons-mall cell lung cancer. Int. J. Cancer, 129, 355-364.
27. Sergeant, G., Penninckx, F. & Topal, B. (2008) Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood: a systematic review. J. Surg. Res., 150, 144-152.
28. Serpil, O., Meral, A., Muzeyyen, O., Ozlem, T., Umit, Y., Mustafa, T. & Ziya, A. (2009) Alkaline phosphatase, cytokeratin 7, cytokeratin 8 in the diagnosis of primary lung adenocarcinoma from 148 pleura fluids specimens. Folia Histochem. Cyto-biol., 47, 87-92.
29. Sher, Y.P., Shih, J.Y., Yang, P.C., Roffler, S.R., Chu, Y.W., Wu, C.W., Yu, C.L. & Peck, K. (2005) Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin. Cancer Res., 11, 173-179.
30. Strati, A., Markou, A., Parisi, C., Politaki, E., Mavroudis, D., Georgoulias, V. & Lianidou, E. (2011) Gene expression profle of circulating tumor cells in breast cancer by R T- qPCR. BMC Cancer, 11, 422.
31. Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K. & Akimitsu, N. (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett., 584, 4575-4580.
32. Toonkel, R.L., Borczuk, A.C. & Powell, C.A. (2010) Tgf-beta signaling pathway in lung adenocarcinoma invasion. J. Thorac. Oncol., 5, 153-157.
33. Uen, Y.H., Lin, S.R., Wu, D.C., Su, Y.C., Wu, J.Y., Cheng, T.L., Chi, C.W. & Wang, J.Y. (2007) Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann. Surg., 246, 1040-1046.
34. Wang, C., Su, Y., Zhang, L., Wang, M., You, J., Zhao, X., Zhang, Z., Liu, J. & Hao, X. (2012) The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarci-noma metastasis. PLoS One, 7, e38046.
35. Wu, C.H., Lin, S.R., Yu, F.J., Wu, D.C., Pan, Y.S., Hsieh, J.S., Huang, S.Y. & Wang, J.Y. (2006) Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int. J. Cancer, 119, 373-379.
36. Xi, L., Nicastri, D.G., El-Hefnawy, T., Hughes, S.J., Luketich, J.D. & Godfrey, T.E. (2007) Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin. Chem., 53, 1206-1215.
37. Young, R., Pailler, E., Billiot, F., Drusch, F., Barthelemy, A., Oulhen, M., Besse, B., Soria, J.C., Farace, F. & Vielh, P. (2012) Circulating tumor cells in lung cancer. Acta Cytol., 56, 655-660.
38. Yu, Y., Xu, G., Cao, J., Jin, S., Man, Y. & Shang, L. (2013) Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR. Oncol. Lett., 5, 1400-1406.